Trial NCT02206763

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-370-1298

Last trial update was posted on 2019-02-01

MeSH Interventions

Erlotinib Hydrochloride N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

EGFR Mutated EGFR TKI Naive Metastatic NSCLC

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID